"Retina Care Center-Baltimore, MD is an eye care center & ophthalmology clinic with retina specialists & vitreoretinal surgeon ophthalmologists providing eye exams, diagnosis & treatment for retina diseases, problems & conditions including age related macular degeneration (AMD), macular diseases, diabetic retinopathy (DR), retinal vascular disease such as retinal vein occlusion & retinal artery occlusion, retinal detachment & tears, retinal membranes & macular hole. Our retina specialists perform retina injections for AMD and Diabetic Retinopathy & laser photocoagulation treatment in our offices & retina surgery including scleral buckle surgery, vitrectomy & pneumatic retinopexy for patients needing retina surgery to preserve vision."

During the past decade, The Retina Care Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Retina Care Center" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Gyroscope Therapeutics Limited" with 3 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Retina Care Center" #1 collaborator was "Novartis Pharmaceuticals" with 3 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Retina Care Center" are "Geographic Atrophy" (7 trials), "Macular Degeneration" (4 trials), "Diabetic Macular Edema" (3 trials), "Dry Age-related Macular Degeneration" (3 trials) and "Macular Degeneration, Age-Related" (2 trials). Many other conditions were trialed in "The Retina Care Center" in a lesser frequency.

Most popular intervention types in "The Retina Care Center" are "Drug" (23 trials), "Other" (5 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (7 trials), "Faricimab" (5 trials), "Aflibercept" (3 trials), "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Retina Care Center" are 25 trials for "All" genders.

Currently, there are NaN active trials in "The Retina Care Center". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in The Retina Care Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Retina Care Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".